How Peptide Purity Is Measured: RP-HPLC, Mass Spectrometry, and Salt Content Determination
A technical guide to peptide analytical chemistry. Reverse-phase HPLC chromatograms, peak integration, electrospray mass spectrometry, net peptide content, and moisture analysis. Purity percentage on a CoA reflects the area under the main peptide peak on a Reverse-Phase HPLC chromatogram at 214/220 nm.
- Purity percentage on a CoA reflects the area under the main peptide peak on a Reverse-Phase HPLC chromatogram at 214/220 nm.
- HPLC purity does NOT account for moisture, residual solvents, or counterion salts (TFA/acetate).
- LC-MS (ESI-MS / MALDI-TOF) confirms molecular identity by verifying monoisotopic and average mass.
- Net Peptide Content (NPC) measures the actual percentage of peptide by weight (typically 70–85% of gross vial weight).
- Karl Fischer titration determines residual moisture (<3% for pharmaceutical grade lyophilization).
| CAS Registry Number | N/A (Analytical Methodology) |
|---|---|
| Molecular Formula | Standard Laboratory Analytical Systems |
| Molecular Mass | N/A |
| Primary Biological Target | Chromatographic & Spectrometric Validation |
| Analytical Purity Standard | ≥99.0% (RP-HPLC, C18, 214/220 nm) |
| Identity Verification | ESI-MS (±0.1 Da) + Karl Fischer Moisture (<3.0%) |
| Lyophilized Storage | -20°C desiccated, protected from UV light (24–36 months) |
| Reconstituted Storage | 2°C–8°C refrigerated (up to 28 days in 0.9% BA BAC water) |
1. Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC)
RP-HPLC is the primary standard for quantifying peptide purity. Peptides are separated based on hydrophobic interactions between the peptide side chains and a stationary phase (typically C18 or C4 silica matrices) using an aqueous/acetonitrile mobile phase gradient containing 0.1% trifluoroacetic acid (TFA). As eluted compounds pass a UV detector set at peptide-bond absorbing wavelengths (214 nm or 220 nm), peak areas are integrated. Purity (%) is calculated as: (Main Peak Area / Total Integrated Peak Area) × 100.
2. Mass Spectrometry (ESI-MS & MALDI-TOF)
While HPLC confirms that a single chromatographic species is present, it cannot confirm that the species is the desired molecule. Mass spectrometry confirms molecular identity. Electrospray Ionization (ESI-MS) or Matrix-Assisted Laser Desorption/Ionization (MALDI-TOF) ionizes the peptide and measures its mass-to-charge ratio (m/z). Observed mass must match theoretical calculated mass within ±0.5–1.0 Da tolerance.
3. The Critical Distinction: Purity vs Net Peptide Content (NPC)
A vial labeled '99% purity' is not 99% peptide by weight. Lyophilized peptides are salts (usually acetate or trifluoroacetate) that also contain trapped structural water molecules. While the chromatographic purity of the peptide fraction is 99%, the Net Peptide Content (NPC)—determined by Amino Acid Analysis (AAA) or elemental nitrogen analysis—typically ranges from 70% to 85%. The remaining 15–30% consists of counterion salts and moisture.
4. Reading Residual Solvents and Karl Fischer Titration
A complete SwissLab Certificate of Analysis includes Karl Fischer coulometric titration to quantify residual moisture (<3.0%) and headspace gas chromatography to verify removal of organic synthesis solvents (acetonitrile, dichloromethane, piperidine). Lyophilization in sterile class-A cleanrooms ensures endotoxin levels remain below 10 EU/mg.
5. Bench Preparation & Assay Reproducibility for How Peptide Purity Is Measured
When designing in-vitro experiments targeting Chromatographic & Spectrometric Validation, normalize dosing across replicates by molar concentration (µM or nM) using the published molecular weight (N/A) and batch counterion composition rather than gross powder weight alone. Log lot numbers, diluent pH, and aliquot dates to ensure batch-to-batch reproducibility across longitudinal experiments.
Peer-Reviewed References & Analytical Standards
- Mant C.T., Chen Y., Yan Z., Popa T.V., Kovacs J.M., Mills J.B., Tripet B.P., Hodges R.S. (2007). HPLC analysis and purification of peptides. Methods in Molecular Biology, 386, 3–55. [PMID: 18604941 ↗]
- Cornish J. et al. (1999). Trifluoroacetate, a contaminant in purified proteins, inhibits proliferation of osteoblasts and chondrocytes. American Journal of Physiology, 277(5), E779–E783. [PMID: 10567002 ↗]
- United States Pharmacopeia (USP-NF) General Chapter <621> Chromatography & <1503> Quality Attributes of Synthetic Peptide Drug Substances. [USP-NF Standards ↗]
Referenced Laboratory Research Reagents
Batch-verified SwissLab catalog entries cited in this monograph
All analytical monographs and chemical data are published strictly for in-vitro laboratory research and scientific reference. Reagents must be handled by qualified personnel wearing appropriate PPE. Not for human or veterinary use.